Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: A case-control study

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 7, 2005, Pages 521-529

  Sangiolo, Dario ^a   Storer, Barry ^a,b   Nash, Richard ^a,b   Corey, Lawrence ^a,b   Davis, Chris ^a   Flowers, Mary ^a,b   Hackman, Robert C ^a,b   Boeckh, Michael ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Dapsone; Hematopoietic stem cell transplantation; Pneumocystis jiroveci

Indexed keywords

COTRIMOXAZOLE; DAPSONE; IMMUNOSUPPRESSIVE AGENT; PENICILLIN V POTASSIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TOXICITY; BLOOD TRANSFUSION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ERYTHROCYTE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; METHEMOGLOBINEMIA; NEUTROPENIA; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DAPSONE; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECI; TRANSPLANTATION, HOMOLOGOUS;

EID: 20844431749     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.04.011     Document Type: Article

References (26)

1. M.J. Krowka E.C. Rosenow H.C. Hoagland Pulmonary complications of bone marrow transplantation Chest 87 1985 237-246
2. E. Walter T. Chauncey M. Boeckh R. Hackman M. Kennedy R. Bowden PCP prophylaxis after marrow transplantation: Efficacy of trimethoprim sulfamethoxazole (TS), role of TS desensitization and IV pentamidine [abstract] ICAAC 125 1993 32
3. J.D. Meyers N. Flournoy J.C. Wade et al. Biology of interstitial pneumonia after marrow transplantation. In: R.P. Gale ed. Recent Advances in Bone Marrow Transplantation 1983 Alan R. Liss New York 405-423
4. M. Boeckh K.A. Marr Infection in hematopoietic stem cell transplantation. In: R.H. Rubin, L.S. Young eds. Clinical Approach to Infection in the Compromised Host 2002 Kluwer Academic/Plenum New York 527-571
5. M. Boeckh Pneumocystis carinii pneumonia: Current prevention and treatment strategies Blood Marrow Transplant Rev. 13 2003 8-10
6. R.A. Nash Overview: Treatment settings and duration of risk for infections Blood Marrow Transplant Rev. 13 2003 4-8
7. O. Lyytikainen T. Ruutu L. Volin et al. Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation Bone Marrow Transplant. 17 1996 1057-1059
8. I.-Z. Tuan D. Dennison D.J. Weisdorf Pneumocystis carinii pneumonitis following bone marrow transplantation Bone Marrow Transplant. 10 1992 267-272
9. T.K. Marras K. Sanders J.H. Lipton H.A. Messner J. Conly C.K. Chan Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation Transplant Infect Dis. 4 2002 66-74
10. J.P. Souza M. Boeckh T.A. Gooley M.E.D. Flowers S.W. Crawford High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis Clin Infect Dis. 29 1999 1467-1471
11. W.M. El-Sadr R.L. Murphy T.M. Yurik et al. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group N Engl J Med. 339 1998 1889-1895
12. W.D. Hardy J. Feinberg D.M. Finkelstein et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021 N Engl J Med. 327 1992 1842-1848
13. M.J. Vasconcelles M.V. Bernardo C. King E.A. Weller J.H. Antin Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections Biol Blood Marrow Transplant. 6 2000 35-43
14. M.M. Schneider A.I. Hoepelman S.J. Eeftinck et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med. 327 1992 1836-1841
15. J. Mallolas L. Zamora J.M. Gatell et al. Primary prophylaxis for Pneumocystis carinii pneumonia: A randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine AIDS 7 1993 59-64
16. G.P. Rizzardi A. Lazzarin M. Musicco et al. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: A two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group. J Infect. 32 1996 123-131
17. T. May C. Beuscart J. Reynes et al. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: A prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Francaise de Prevention des Maladies Infectieuses J Acquir Immune Defic Syndr. 7 1994 457-462
18. F.X. Mahon A. Sadoun E. Benz-Lemoine F. Roblot-Casenave F. Guilhot J. Tanzer Possible prevention of Pneumocystis carinii pneumonia by pentamidine aerosol after bone marrow transplantation Bone Marrow Transplant. 8 1991 64-65
19. C.M. Machado M.C. Macedo R.S. Medeiros et al. Primary Pneumocystis carinii prophylaxis with aerosolized pentamidine after bone marrow transplantation Acta Haematol. 99 1998 54-56
20. H. Link H.F. Vohringer F. Wingen B. Bragas A. Schwardt G. Ehninger Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT Bone Marrow Transplant. 11 1993 403-406
21. H.C. Maltezou D. Petropoulos M. Choroszy et al. Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation [review] Bone Marrow Transplant. 20 1997 879-881
22. S.A. Bozzette D.M. Finkelstein S.A. Spector et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 332 1995 693-699
23. D.C. McMillan J.V. Simson R.A. Budinsky D.J. Jollow Dapsone-induced hemolytic anemia: Effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes J Pharmacol Exp Ther. 274 1995 540-547
24. T.P. Reilly P.M. Woster C.K. Svensson Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: Implications for differences in adverse drug reactions J Pharmacol Exp Ther. 288 1999 951-959
25. Centers for Disease Control and Prevention Infectious Disease Society of America, American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients MMWR Morb Mortal Wkly Rep. 49 2000 1-125
26. P.K. Andersen O. Borgan R.D. Gill N. Keiding Statistical Models Based on Counting Processes 1993 Springer-Verlag New York